Related Experiment Video
Updated: Jun 17, 2025

Author Spotlight: Unveiling Prognostic Indicators in Heart Failure - The Role of Phase Angle and Bioelectrical Impedance Analysis
Published on: June 30, 2023
Patient Selection and End Point Definitions for Decongestion Studies in Acute Decompensated Heart Failure: Part 2
Gabriel Georges1, Marat Fudim2, Daniel Burkhoff3
1Quebec Heart and Lung Institute, Quebec City, Quebec, Canada.
Abstract:
Congestion is the most common manifestation of acute decompensated heart failure (ADHF). Residual congestion despite initial medical therapy is common and is recognized to be associated with worse outcomes; however, there are currently no standardized definition regarding decongestion end point. In the second part of this 2-part review, we provide a critical appraisal of decongestion definitions previously used in ADHF studies, review alternative metrics to define severity of volume overload, and propose a more granular 4-class congestion grading scheme and decongestion end point definitions that could potentially be included in future ADHF trials and consensus definitions.
More Related Videos
05:58Testing Acetylcholine Followed by Adenosine for Invasive Diagnosis of Coronary Vasomotor Disorders
Published on: February 3, 2021
07:41Induction and Phenotyping of Acute Right Heart Failure in a Large Animal Model of Chronic Thromboembolic Pulmonary Hypertension
Published on: March 17, 2022
Related Concept Videos
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Upper Respiratory Drugs: Decongestants
Most decongestants are readily available over-the-counter in...
Heart Failure Drugs: β-Blockers
Heart Failure Drugs: Diuretics
Pathophysiology of Heart Failure